Variant report
Variant | nsv965595 |
---|---|
Chromosome Location | chr5:15208976-15219649 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:15207572..15210660-chr5:15213009..15215817,3 | K562 | blood: | |
2 | chr5:15217079..15219717-chr5:15220114..15222884,2 | MCF-7 | breast: | |
3 | chr5:15208843..15210800-chr5:15211236..15213348,2 | K562 | blood: | |
4 | chr5:15207572..15210660-chr5:15213009..15215817,3 | K562 | blood: | |
5 | chr5:15208843..15210800-chr5:15211236..15213348,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs535917962 | chr5:15209039-15209040 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs185429414 | chr5:15209043-15209044 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs572915580 | chr5:15209166-15209167 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs540220002 | chr5:15209173-15209174 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs558922367 | chr5:15209201-15209202 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs553398938 | chr5:15209224-15209225 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs577185016 | chr5:15209272-15209273 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs138570740 | chr5:15209291-15209292 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs539691597 | chr5:15209309-15209310 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs10070527 | chr5:15209311-15209312 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs73750460 | chr5:15209337-15209338 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs542802097 | chr5:15209347-15209348 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs71595934 | chr5:15209381-15209382 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs561029356 | chr5:15209388-15209389 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs528494382 | chr5:15209409-15209410 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs36055748 | chr5:15209412-15209413 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs546560174 | chr5:15209464-15209465 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs141657621 | chr5:15209499-15209500 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs79864844 | chr5:15209508-15209509 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs574151206 | chr5:15209511-15209512 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs551154815 | chr5:15209589-15209590 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs569395350 | chr5:15209735-15209736 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs536841411 | chr5:15209739-15209740 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs548016603 | chr5:15209767-15209768 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs73057965 | chr5:15209774-15209775 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs375177340 | chr5:15209801-15209802 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs149470087 | chr5:15209870-15209871 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs189839922 | chr5:15209913-15209914 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs181444067 | chr5:15209919-15209920 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs537702501 | chr5:15209983-15209984 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs186554060 | chr5:15209997-15209998 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs114482854 | chr5:15210064-15210065 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs144385677 | chr5:15210071-15210072 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs10475039 | chr5:15210091-15210092 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs191455957 | chr5:15210115-15210116 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs540241113 | chr5:15210143-15210144 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs2121181 | chr5:15210301-15210302 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs532534068 | chr5:15210308-15210309 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs115239221 | chr5:15210317-15210318 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs182970121 | chr5:15210350-15210351 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs563231749 | chr5:15210351-15210352 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs186180358 | chr5:15210352-15210353 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs544476388 | chr5:15210378-15210379 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs530260578 | chr5:15210406-15210407 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs548772204 | chr5:15210422-15210423 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs191030525 | chr5:15210423-15210424 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs182179311 | chr5:15210426-15210427 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs35079160 | chr5:15210431-15210432 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs73057970 | chr5:15210444-15210445 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs73057972 | chr5:15210455-15210456 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
abnormal development | 18461090 | CNVD |
Lung cancer | 19547694 | CNVD |
Cri-du chat syndrome | 22283845 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Cancer | 21183584 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 17133270 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Multiple myeloma | 17550852 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Breast cancer | 21858162 | CNVD |
Prostate cancer | 18632612 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 16608533 | CNVD |
Anaplastic large cell lymphoma | 18179710 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Intellectual disability | 22102821 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Breast cancer | 21364760 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Acute lymphoblastic leukemia | 17640729 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Lung cancer | 16740712 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Schizophrenia | 23813976 | CNVD |
Breast cancer | 21611746 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:15209000-15209400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr5:15209200-15209600 | Enhancers | A549 | lung |
3 | chr5:15209200-15209800 | Enhancers | Placenta Amnion | Placenta Amnion |
4 | chr5:15209400-15209800 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
5 | chr5:15209400-15209800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
6 | chr5:15209400-15209800 | Enhancers | Fetal Heart | heart |
7 | chr5:15209800-15211200 | Weak transcription | Placenta Amnion | Placenta Amnion |
8 | chr5:15211200-15211400 | Enhancers | Placenta Amnion | Placenta Amnion |
9 | chr5:15214800-15215400 | Enhancers | Cortex derived primary cultured neurospheres | brain |
10 | chr5:15214800-15215600 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
11 | chr5:15215000-15215200 | Enhancers | Aorta | Aorta |
12 | chr5:15215200-15216800 | Weak transcription | Aorta | Aorta |
13 | chr5:15216800-15217000 | ZNF genes & repeats | Aorta | Aorta |
14 | chr5:15218600-15222000 | Enhancers | Placenta | Placenta |